0001376474-24-000535.txt : 20240924 0001376474-24-000535.hdr.sgml : 20240924 20240924145137 ACCESSION NUMBER: 0001376474-24-000535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240919 FILED AS OF DATE: 20240924 DATE AS OF CHANGE: 20240924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galkin Vladimir CENTRAL INDEX KEY: 0002020621 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41392 FILM NUMBER: 241319484 MAIL ADDRESS: STREET 1: 10900 NW 97TH STREET, #102 CITY: MIAMI STATE: FL ZIP: 33178 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innovative Eyewear Inc CENTRAL INDEX KEY: 0001808377 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 842794274 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11900 BISCAYNE BLVD STREET 2: STE 630 CITY: MIAMI STATE: FL ZIP: 33181 BUSINESS PHONE: 786-910-1898 MAIL ADDRESS: STREET 1: 66 W FLAGLER ST. SUITE 900 STREET 2: STE 216 CITY: MIAMI STATE: FL ZIP: 33130 4 1 vg_4.xml FORM 4 FILING X0508 4 2024-09-19 0001808377 Innovative Eyewear Inc LUCY 0002020621 Galkin Vladimir 10900 NW 97TH STREET, #102 MIAMI FL 33178 false false true false false Common Stock, par value $0.00001 2024-09-19 4 P false 124562 9.15 A 612692 I See footnote Common Stock, par value $0.00001 2024-09-19 4 P false 110038 8.97 A 722730 I See footnote Common Stock, par value $0.00001 2024-09-19 4 P false 25648 8.62 A 748378 I See footnote Common Stock, par value $0.00001 2024-09-19 4 P false 37195 8.10 A 785573 I See footnote Common Stock, par value $0.00001 2024-09-19 4 S false 780 9.79 D 784793 I See footnote Common Stock, par value $0.00001 2024-09-19 4 S false 16223 9.50 D 768570 I See footnote Common Stock, par value $0.00001 2024-09-19 4 S false 24424 8.79 D 744146 I See footnote Common Stock, par value $0.00001 2024-09-19 4 S false 901 8.50 D 743245 I See footnote The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4. The purchases were executed in multiple trades at prices ranging from $9.01 to $9.20. The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose. The purchases were executed in multiple trades at prices ranging from $8.76 to $9.00. The purchases were executed in multiple trades at prices ranging from $8.51 to $8.75. The purchases were executed in multiple trades at prices ranging from $8.10 to $8.27. The sales were executed in multiple trades at a price of $9.79. The sales were executed in multiple trades at a price of $9.50. The sales were executed in multiple trades at a price of $8.79. The sales were executed in multiple trades at a price of $8.50. /s/ Vladimir Galkin, Attorney in Fact 2024-09-24